Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02191696 · ClinicalTrials.gov registry record
Observational Study of ICD and Pacemaker Sensing in the Presence of IMED-4 Operation
A clinical trial of Heart Failure, sponsored by Intersection Medical.
- Completed
- Registry status
- 24
- Enrollment target
- 2
- Study locations
NCT02191696: Completed study of Heart Failure, sponsored by Intersection Medical.
NCT02191696 is a study of Heart Failure that has completed, run by Intersection Medical. The registered enrollment target is 24 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02191696, a study of Heart Failure, has completed, sponsored by Intersection Medical.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose is to monitor far field sensing artifacts of CRM devices in the presence of the IMED-4
Conditions Studied
Interventions
- DEVICE IMED-4 recording
Study Locations (2)
California
- North Coast Cardiology - Encinitas
- Desert Heart - Palm Springs
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2014-06 |
| Est. Completion | 2015-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02191696
The ClinicalTrials.gov registry entry for NCT02191696 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (99% lower). The listed sponsor is Intersection Medical, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which IMED-4 recording is the first listed.
NCT02191696 reports 2 study locations spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT02191696 about?
NCT02191696 is a clinical study titled "Observational Study of ICD and Pacemaker Sensing in the Presence of IMED-4 Operation". The purpose is to monitor far field sensing artifacts of CRM devices in the presence of the IMED-4
What is the current status of trial NCT02191696?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2014-06. Estimated completion is 2015-01.
What conditions does trial NCT02191696 study?
This clinical trial studies the following conditions: Heart Failure.
What interventions are being tested in trial NCT02191696?
The interventions under investigation include: IMED-4 recording (DEVICE).
Who is sponsoring clinical trial NCT02191696?
This trial is sponsored by Intersection Medical, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02191696 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
RECRUITING · Phase 3
-
Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure
RECRUITING
-
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
RECRUITING
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.